Compare Multitrend Indo Tbk (BABY) vs Metro Healthcare Indonesia Tbk. (CARE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multitrend Indo Tbk vs Metro Healthcare Indonesia Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp174 (market cap 485.32B, 589.3K 24h volume), while Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.16T, 208.8K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 29.2× Multitrend Indo Tbk's market cap, and Multitrend Indo Tbk is more actively traded (589.3K versus 208.8K). Which is the better fit depends on your goals.
| BABY | CARE | |
|---|---|---|
Market Cap | 485.32B | 14.16T |
Volume | 589.3K | 208.8K |
Lot | 5.89K | 2.09K |
Turnover | 101.82M | 89.41M |
Average Price | 172.78 | 428.22 |
Value | 101.82M | 89.41M |
Indicative Equilibrium Price | 174 | 428 |
Indicative Equilibrium Volume | 60 | 3 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multitrend Indo Tbk
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →About Metro Healthcare Indonesia Tbk.
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →
